← Leaderboards
L David Sibley
Washington University
$48,261,605
Attributed
$53,866,696
Total exposure
25
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$53,866,696 · 25
By mechanism
R01$50,014,380 · 15
R21$3,426,918 · 8
S10$410,398 · 1
R13$15,000 · 1
Top collaborators
- Arnab Kumar Chatterjee6 shared
- James W Janetka4 shared
- Rui Zhang2 shared
Most similar at Washington University
Same institution · by research overlap
- Arnab Kumar Chatterjee$11,706,278
- Sharon Celeste Morley$6,198,580
- Rui Zhang$2,672,897
Others in their field
Top investigators on “Toxoplasma Gondii”
- John C Boothroyd · Stanford University$21,342,994
- Christopher A Hunter · University Of Pennsylvania$20,595,527
- Michael W White · University Of California Riverside$17,265,886
- Vernon Bruce Carruthers · Johns Hopkins University$15,672,870
- Gary E Ward · University Of Vermont & St Agric College$14,197,597
- William J Sullivan Jr · Indiana University Indianapolis$13,937,697
Research focus
Toxoplasma GondiiParasitesInfectionImmunocompromised HostCellsToxoplasmosisIn VivoIn VitroMolecularBaseGrowthChronicMouse ModelFutureMediatingPathway InteractionsGenesGeneticTissuesProteinsImmune SystemAnimalsAcuteLead
Grant awards (115)
Exploiting Diversity-Oriented Chemical Synthesis for Combating Chronic Parasitic Infection$1,228,981
R01 · FY2025 · AI · contact PI
Regulation of host cell egress by Toxoplasma gondii$1,227,508
R01 · FY2025 · AI · contact PI
Optimizing CDPK1 inhibitors for chronic toxoplasmosis$777,256
R01 · FY2025 · AI · contact PI
Influence of microbial metabolites on mitosome function in Cryptosporidium$715,894
R01 · FY2025 · AI · contact PI
Structure and Function of the Conoid in Toxoplasma$706,598
R01 · FY2025 · AI
Genetic Basis of Host Infectivity by Cryptosporidium$656,207
R01 · FY2025 · AI · contact PI
Exploiting Diversity-Oriented Chemical Synthesis for Combating Chronic Parasitic Infection$939,834
R01 · FY2024 · AI · contact PI
Optimizing CDPK1 inhibitors for chronic toxoplasmosis$777,256
R01 · FY2024 · AI · contact PI
Structure and Function of the Conoid in Toxoplasma$738,388
R01 · FY2024 · AI
Genetic Basis of Host Infectivity by Cryptosporidium$690,377
R01 · FY2024 · AI · contact PI
Molecular Basis of Human Toxoplasmosis$668,225
R01 · FY2024 · AI · contact PI
Regulation of host cell egress by Toxoplasma gondii$613,754
R01 · FY2024 · AI · contact PI
Cryptosporidiosis and Oral Tolerance$194,375
R21 · FY2024 · AI · contact PI
Exploiting Diversity-Oriented Chemical Synthesis for Combating Chronic Parasitic Infection$1,136,794
R01 · FY2023 · AI · contact PI
Optimizing CDPK1 inhibitors for chronic toxoplasmosis$780,588
R01 · FY2023 · AI · contact PI
Effect of Microbial Metabolites on Growth of Cryptosporidium$670,711
R01 · FY2023 · AI · contact PI
Molecular Basis of Human Toxoplasmosis$668,225
R01 · FY2023 · AI · contact PI
Regulation of host cell egress by Toxoplasma gondii$614,411
R01 · FY2023 · AI · contact PI
Cryptosporidiosis and Oral Tolerance$233,501
R21 · FY2023 · AI · contact PI
Exploiting Diversity-Oriented Chemical Synthesis for Combating Chronic Parasitic Infection$1,137,363
R01 · FY2022 · AI · contact PI
Optimizing CDPK1 inhibitors for chronic toxoplasmosis$787,253
R01 · FY2022 · AI · contact PI
Effect of Microbial Metabolites on Growth of Cryptosporidium$670,711
R01 · FY2022 · AI · contact PI
Molecular Basis of Human Toxoplasmosis$668,225
R01 · FY2022 · AI · contact PI
Regulation of host cell egress by Toxoplasma gondii$621,648
R01 · FY2022 · AI · contact PI
Reactivation of Chronic Toxoplasmosis$194,885
R21 · FY2022 · AI · contact PI
Exploiting Diversity-Oriented Chemical Synthesis for Combating Chronic Parasitic Infection$1,137,472
R01 · FY2021 · AI · contact PI
Effect of Microbial Metabolites on Growth of Cryptosporidium$670,711
R01 · FY2021 · AI · contact PI
Molecular Basis of Human Toxoplasmosis$668,225
R01 · FY2021 · AI · contact PI
Reactivation of Chronic Toxoplasmosis$248,237
R21 · FY2021 · AI · contact PI
Secretory proteins of Cryptosporidium parvum$197,736
R21 · FY2021 · AI · contact PI
Interferon-mediated control mechanisms in human cells$196,875
R21 · FY2021 · AI · contact PI
Exploiting Diversity-Oriented Chemical Synthesis for Combating Chronic Parasitic Infection$1,062,400
R01 · FY2020 · AI · contact PI
Effect of Microbial Metabolites on Growth of Cryptosporidium$683,892
R01 · FY2020 · AI · contact PI
Molecular Basis of Human Toxoplasmosis$667,341
R01 · FY2020 · AI · contact PI
Secretory proteins of Cryptosporidium parvum$249,764
R21 · FY2020 · AI · contact PI
Interferon-mediated control mechanisms in human cells$236,250
R21 · FY2020 · AI · contact PI
Molecular Basis of Human Toxoplasmosis$524,416
R01 · FY2019 · AI · contact PI
PROTEIN SECRETION & INTRACELLULAR SURVIVAL BY TOXOPLASMA$506,896
R01 · FY2019 · AI · contact PI
DEVELOPING IN VITRO CULTURE SYSTEMS FOR CRYPTOSPORIDIUM HOMINIS CULTIVATION$195,937
R21 · FY2019 · AI · contact PI
Molecular Basis of Human Toxoplasmosis$524,416
R01 · FY2018 · AI · contact PI
PROTEIN SECRETION & INTRACELLULAR SURVIVAL BY TOXOPLASMA$506,896
R01 · FY2018 · AI · contact PI
DEVELOPING IN VITRO CULTURE SYSTEMS FOR CRYPTOSPORIDIUM HOMINIS CULTIVATION$232,500
R21 · FY2018 · AI · contact PI
INHIBITION OF STAT TRANSCRIPTION BY TOXOPLASMA$190,625
R21 · FY2018 · AI · contact PI
Molecular Basis of Human Toxoplasmosis$524,416
R01 · FY2017 · AI · contact PI
PROTEIN SECRETION & INTRACELLULAR SURVIVAL BY TOXOPLASMA$506,896
R01 · FY2017 · AI · contact PI
INHIBITION OF STAT TRANSCRIPTION BY TOXOPLASMA$228,750
R21 · FY2017 · AI · contact PI
Molecular Basis of Human Toxoplasmosis$524,416
R01 · FY2016 · AI · contact PI
PROTEIN SECRETION & INTRACELLULAR SURVIVAL BY TOXOPLASMA$506,896
R01 · FY2016 · AI · contact PI
Molecular Basis of Human Toxoplasmosis$537,541
R01 · FY2015 · AI · contact PI
PROTEIN SECRETION & INTRACELLULAR SURVIVAL BY TOXOPLASMA$506,896
R01 · FY2015 · AI · contact PI
TARGETING ESSENTIAL ROP KINASES IN TOXOPLASMA$430,048
R01 · FY2015 · AI · contact PI
DESIGNING SELECTIVE INHIBITORS OF CALCIUM-DEPENDENT KINASES IN PARASITES$294,939
R01 · FY2015 · AI · contact PI
TARGETING ESSENTIAL ROP KINASES IN TOXOPLASMA$430,048
R01 · FY2014 · AI · contact PI
Protein Secretion and Intracellular Survival by Toxoplasma$408,141
R01 · FY2014 · AI · contact PI
DESIGNING SELECTIVE INHIBITORS OF CALCIUM-DEPENDENT KINASES IN PARASITES$368,011
R01 · FY2014 · AI · contact PI
DESIGNING SELECTIVE INHIBITORS OF CALCIUM-DEPENDENT KINASES IN PARASITES$448,882
R01 · FY2013 · AI · contact PI
TARGETING ESSENTIAL ROP KINASES IN TOXOPLASMA$404,244
R01 · FY2013 · AI · contact PI
Molecular Basis of Toxoplasmosis$386,737
R01 · FY2013 · AI · contact PI
Protein Secretion and Intracellular Survival by Toxoplasma$383,653
R01 · FY2013 · AI · contact PI
Infectivity and Transmission of Toxoplasmosis$381,225
R01 · FY2013 · AI · contact PI
DESIGNING SELECTIVE INHIBITORS OF CALCIUM-DEPENDENT KINASES IN PARASITES$504,941
R01 · FY2012 · AI · contact PI
TARGETING ESSENTIAL ROP KINASES IN TOXOPLASMA$430,048
R01 · FY2012 · AI · contact PI
Molecular Basis of Toxoplasmosis$411,422
R01 · FY2012 · AI · contact PI
Protein Secretion and Intracellular Survival by Toxoplasma$408,141
R01 · FY2012 · AI · contact PI
Infectivity and Transmission of Toxoplasmosis$405,559
R01 · FY2012 · AI · contact PI
TARGETING ESSENTIAL ROP KINASES IN TOXOPLASMA$430,219
R01 · FY2011 · AI · contact PI
Molecular Basis of Toxoplasmosis$411,586
R01 · FY2011 · AI · contact PI
Protein Secretion and Intracellular Survival by Toxoplasma$408,306
R01 · FY2011 · AI · contact PI
Infectivity and Transmission of Toxoplasmosis$405,717
R01 · FY2011 · AI · contact PI
Targeting the Actin Cytoskeleton in Parasites$342,820
R01 · FY2011 · AI · contact PI
Protein Secretion and Intracellular Survival by Toxoplasma$425,418
R01 · FY2010 · AI · contact PI
Molecular Basis of Toxoplasmosis$415,731
R01 · FY2010 · AI · contact PI
Infectivity and Transmission of Toxoplasmosis$409,801
R01 · FY2010 · AI · contact PI
DEVELOPING KINASE INHIBITORS TO COUNTERACT PARASITE VIRULENCE$379,301
R01 · FY2010 · AI · contact PI
Targeting the Actin Cytoskeleton in Parasites$346,832
R01 · FY2010 · AI · contact PI
2010 Biology of Host-Parasite Interactions Gordon Research Conference$15,000
R13 · FY2010 · AI · contact PI
Molecular Basis of Toxoplasmosis$420,696
R01 · FY2009 · AI · contact PI
Infectivity and Transmission of Toxoplasmosis$414,883
R01 · FY2009 · AI · contact PI
DEVELOPING KINASE INHIBITORS TO COUNTERACT PARASITE VIRULENCE$379,301
R01 · FY2009 · AI · contact PI
Protein secretion & intracellular survival by Toxoplasma$355,788
R01 · FY2009 · AI · contact PI
Targeting the Actin Cytoskeleton in Parasites$350,335
R01 · FY2009 · AI · contact PI
Molecular Basis of Toxoplasmosis$355,788
R01 · FY2008 · AI · contact PI
Protein secretion & intracellular survival by Toxoplasma$355,788
R01 · FY2008 · AI · contact PI
Infectivity and Transmission of Toxoplasmosis$355,788
R01 · FY2008 · AI · contact PI
Targeting the Actin Cytoskeleton in Parasites$350,335
R01 · FY2008 · AI · contact PI
Molecular Basis of Toxoplasmosis$362,679
R01 · FY2007 · AI · contact PI
Infectivity and Transmission of Toxoplasmosis$362,679
R01 · FY2007 · AI · contact PI
Protein secretion & intracellular survival by Toxoplasma$362,679
R01 · FY2007 · AI · contact PI
Targeting the Actin Cytoskeleton in Parasites$358,191
R01 · FY2007 · AI · contact PI
Mucosal Immunity to Toxoplasma gondii$221,449
R21 · FY2007 · AI · contact PI
Molecular Basis of Toxoplasmosis$373,511
R01 · FY2006 · AI · contact PI
Infectivity and Transmission of Toxoplasmosis$373,511
R01 · FY2006 · AI · contact PI
Protein secretion & intracellular survival by Toxoplasma$373,511
R01 · FY2006 · AI · contact PI
Calcium ATPases in Apicomplexan Parasites as Potential D$224,107
R21 · FY2006 · AI · contact PI
Mucosal Immunity to Toxoplasma gondii$190,677
R21 · FY2006 · AI · contact PI
Infectivity and Transmission of Toxoplasmosis$382,500
R01 · FY2005 · AI
Molecular Basis of Toxoplasmosis$382,500
R01 · FY2005 · AI
Protein secretion &intracellular survival by Toxoplasma$382,500
R01 · FY2005 · AI
Calcium ATPases in Apicomplexan Parasites as Potential D$191,250
R21 · FY2005 · AI
Infectivity and Transmission of Toxoplasmosis$382,500
R01 · FY2004 · AI
Molecular Basis of Toxoplasmosis$382,500
R01 · FY2004 · AI
PROTEIN SECRETION AND INTRACELLULAR SURVIVAL BY TOXOPLAS$308,000
R01 · FY2004 · AI
MOLECULAR BASIS OF TOXOPLASMOSIS$366,929
R01 · FY2003 · AI
GENE DISCOVERY IN TOXOPLASMA GONDII$362,259
R01 · FY2003 · AI
PROTEIN SECRETION AND INTRACELLULAR SURVIVAL BY TOXOPLAS$308,000
R01 · FY2003 · AI
Confocal Microscope for Microbiology$410,398
S10 · FY2002 · RR
GENE DISCOVERY IN TOXOPLASMA GONDII$376,952
R01 · FY2002 · AI
MOLECULAR BASIS OF TOXOPLASMOSIS$356,243
R01 · FY2002 · AI
PROTEIN SECRETION AND INTRACELLULAR SURVIVAL BY TOXOPLAS$308,000
R01 · FY2002 · AI
GENE DISCOVERY IN TOXOPLASMA GONDII$382,017
R01 · FY2001 · AI
MOLECULAR BASIS OF TOXOPLASMOSIS$345,866
R01 · FY2001 · AI
PROTEIN SECRETION AND INTRACELLULAR SURVIVAL BY TOXOPLAS$308,250
R01 · FY2001 · AI
GENE DISCOVERY IN TOXOPLASMA GONDII$500,656
R01 · FY2000 · AI
MOLECULAR BASIS OF TOXOPLASMOSIS$335,792
R01 · FY2000 · AI
PROTEIN SECRETION AND INTRACELLULAR SURVIVAL BY TOXOPLAS$309,750
R01 · FY2000 · AI